Liver Bid-suppression for treatment of fibrosis associated with nonalcoholic steatohepatitis

BACKGROUND & AIMS: Liver fibrosis is the most worrisome feature of Nonalcoholic Steatohepatitis (NASH). Growing evidence supports a link between hepatocyte apoptosis and liver fibrogenesis. Our aim was to determine the therapeutic efficacy and safety of liver Bid, a key pro-apoptotic molecule, s...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Hepatol
Prif Awduron: Eguchi, Akiko, Mollerat Du Jeu, Xavier De, Johnson, Casey D., Nektaria, Andronikou, Feldstein, Ariel E.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2015
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4761314/
https://ncbi.nlm.nih.gov/pubmed/26555271
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jhep.2015.11.002
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg